Back to Journals » Therapeutics and Clinical Risk Management » Volume 6 » default

Therapeutics and Clinical Risk Management


Archive: Volume 6, 2010

Reduced exercise capacity in persons with Down syndrome: cause, effect, and management

Goncalo V Mendonca, Fernando D Pereira1 Bo Fernhall

Therapeutics and Clinical Risk Management 2010, 6:601-610

Published Date: 8 December 2010

Does smoking really protect from recurrent aphthous stomatitis?

Faleh A Sawair

Therapeutics and Clinical Risk Management 2010, 6:573-577

Published Date: 22 November 2010

Comparative evaluation of prophylactic single-dose intravenous antibiotic with postoperative antibiotics in elective urologic surgery

Mohammad K Moslemi, Seyed M Moosavi Movahed, Akram Heidari, et al

Therapeutics and Clinical Risk Management 2010, 6:551-556

Published Date: 9 November 2010

New advances in the treatment of gout: review of pegloticase

Mattheus K Reinders, Tim L Th A Jansen

Therapeutics and Clinical Risk Management 2010, 6:543-550

Published Date: 27 October 2010

Portal vein thrombosis in a patient with HCV cirrhosis and combined hemophilia A and thrombophilia V Leiden

Nikos Eleftheriadis, Pantelis Makris

Therapeutics and Clinical Risk Management 2010, 6:539-541

Published Date: 26 October 2010

Emerging clinical role of ranolazine in the management of angina

David S Vadnais, Nanette K Wenger

Therapeutics and Clinical Risk Management 2010, 6:517-530

Published Date: 14 October 2010

Treatment of Cushing disease: overview and recent findings

Tatiana Mancini, Teresa Porcelli, Andrea Giustina

Therapeutics and Clinical Risk Management 2010, 6:505-516

Published Date: 12 October 2010

Role of teriparatide in treatment of glucocorticoid-induced osteoporosis

Arthur N Lau, Jonathan D Adachi

Therapeutics and Clinical Risk Management 2010, 6:497-503

Published Date: 12 October 2010

Pegylated liposomal doxorubicin in the management of ovarian cancer

Gabriella Ferrandina, Giacomo Corrado, Angelo Licameli, et al

Therapeutics and Clinical Risk Management 2010, 6:463-483

Published Date: 29 September 2010

An improved delivery system for bladder irrigation

Mohammad K Moslemi, Mojtaba Rajaei

Therapeutics and Clinical Risk Management 2010, 6:459-462

Published Date: 30 September 2010

Gastrointestinal stromal tumor (GIST) recurrence following surgery: review of the clinical utility of imatinib treatment

Isabelle Deshaies, Jovenel Cherenfant, Niraj J Gusani, et al

Therapeutics and Clinical Risk Management 2010, 6:453-458

Published Date: 22 September 2010

Intravenous lipid emulsion for treatment of local anesthetic toxicity

M Caroline Kosh, April D Miller, Jill E Michels

Therapeutics and Clinical Risk Management 2010, 6:449-451

Published Date: 24 September 2010

Microbial contamination of nonsterile pharmaceuticals in public hospital settings

Veronica Mugoyela, Kennedy D Mwambete

Therapeutics and Clinical Risk Management 2010, 6:443-448

Published Date: 10 September 2010

Role of tipranavir in treatment of patients with multidrug-resistant HIV

Joshua D Courter, Colleen J Teevan, Michael H Li, et al

Therapeutics and Clinical Risk Management 2010, 6:431-441

Published Date: 23 September 2010

Growth hormone deficiency and cerebral palsy

Jesús Devesa, Nerea Casteleiro, Cristina Rodicio, et al

Therapeutics and Clinical Risk Management 2010, 6:413-418

Published Date: 7 September 2010

Emerging oral treatments in multiple sclerosis – clinical utility of cladribine tablets

Claudio Gasperini, Serena Ruggieri, Carlo Pozzilli

Therapeutics and Clinical Risk Management 2010, 6:391-399

Published Date: 31 August 2010

Molecular mechanisms and treatment strategies for Dupuytren’s disease

David B O’Gorman, Linda Vi, Bing Siang Gan

Therapeutics and Clinical Risk Management 2010, 6:383-390

Published Date: 27 August 2010

Current and emerging treatments for the management of osteogenesis imperfecta

Elena Monti, Monica Mottes, Paolo Fraschini, et al

Therapeutics and Clinical Risk Management 2010, 6:367-381

Published Date: 24 August 2010

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis

Michael Pazianas, Cyrus Cooper, F Hal Ebetino, et al

Therapeutics and Clinical Risk Management 2010, 6:325-343

Published Date: 19 July 2010

Optimal therapy in Gaucher disease

Ozlem Goker-Alpan

Therapeutics and Clinical Risk Management 2010, 6:315-323

Published Date: 5 July 2010

Antibiotic prescribing practices by dentists: a review

Najla Saeed Dar-Odeh, Osama Abdalla Abu-Hammad, Mahmoud Khaled Al-Omiri, et al

Therapeutics and Clinical Risk Management 2010, 6:301-306

Published Date: 21 June 2010

Critical appraisal of a fixed combination of esomeprazole and low dose aspirin in risk reduction

Ravi Vachhani, Doumit Bouhaidar, Alvin Zfass, et al

Therapeutics and Clinical Risk Management 2010, 6:287-292

Published Date: 22 June 2010

Review of mifamurtide in the treatment of patients with osteosarcoma

Leo Kager, Ulrike Pötschger, Stefan Bielack

Therapeutics and Clinical Risk Management 2010, 6:279-286

Published Date: 15 June 2010

Investigation of clinical interaction between omeprazole and tacrolimus in CYP3A5 non-expressors, renal transplant recipients

Paraskevi F Katsakiori, Eirini P Papapetrou, Dimitrios S Goumenos, et al

Therapeutics and Clinical Risk Management 2010, 6:265-269

Published Date: 4 June 2010

Management of ANCA-associated vasculitis: Current trends and future prospects

Sally Hamour, Alan D Salama, Charles D Pusey

Therapeutics and Clinical Risk Management 2010, 6:253-264

Published Date: 3 June 2010

Maximum opening of the mouth by mouth prop during dental procedures increases the risk of upper airway constriction

Hiroshi Ito, Hiroyoshi Kawaai, Shinya Yamazaki, et al

Therapeutics and Clinical Risk Management 2010, 6:239-248

Published Date: 12 May 2010

Serum glutathione transferase does not respond to indole-3-carbinol: A pilot study

Daniel R McGrath, Hamid Frydoonfar, Joshua J Hunt, et al

Therapeutics and Clinical Risk Management 2010, 6:225-231

Published Date: 24 May 2010

Obesity is not associated with contrast nephropathy

Navin Jaipaul, Rendell Manalo, Seyed-Ali Sadjadi, et al

Therapeutics and Clinical Risk Management 2010, 6:213-217

Published Date: 5 May 2010

Equitable access to HCV care in HIV-HCV co-infection can be achieved despite barriers to health care provision

Curtis L Cooper, Celine Giordano, Dave Mackie, et al

Therapeutics and Clinical Risk Management 2010, 6:207-212

Published Date: 20 April 2010

Seven years’ experience with alendronate in postmenopausal Japanese women with osteoporosis

Jun Iwamoto, Yoshihiro Sato, Mitsuyoshi Uzawa, et al

Therapeutics and Clinical Risk Management 2010, 6:201-206

Published Date: 20 April 2010

Ropinirole in restless legs syndrome and periodic limb movement disorder

Daniel Erichsen, Raffaelle Ferri, David Gozal

Therapeutics and Clinical Risk Management 2010, 6:173-182

Published Date: 14 April 2010

Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis

Linda L Hushaw, Ray Sawaqed, Ghaleb Sweis, et al

Therapeutics and Clinical Risk Management 2010, 6:143-152

Published Date: 16 March 2010

Topical calcineurin inhibitors in systemic lupus erythematosus

Christos E Lampropoulos, David P D’Cruz

Therapeutics and Clinical Risk Management 2010, 6:95-101

Published Date: 13 April 2010

Abacavir/lamivudine combination in the treatment of HIV: a review

Geetha Sivasubramanian, Emmanuel Frempong-Manso, Rodger D MacArthur

Therapeutics and Clinical Risk Management 2010, 6:83-94

Published Date: 25 February 2010

Managing opioid-induced constipation in advanced illness: focus on methylnaltrexone bromide

Katri Elina Clemens, Eberhard Klaschik

Therapeutics and Clinical Risk Management 2010, 6:77-82

Published Date: 11 February 2010

Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol

Peter N Huynh, Lyne G Scott, Kenny YC Kwong

Therapeutics and Clinical Risk Management 2010, 6:65-75

Published Date: 8 February 2010

Profile of etravirine for the treatment of HIV infection

Alice Tseng, Rodger D MacArthur

Therapeutics and Clinical Risk Management 2010, 6:49-58

Published Date: 21 January 2010

Tenofovir-associated bone density loss

Iwen F Grigsby, Lan Pham, Louis M Mansky, et al

Therapeutics and Clinical Risk Management 2010, 6:41-47

Published Date: 24 December 2009

Current and emerging treatment options for Graves’ hyperthyroidism

Prakash Abraham, Shamasunder Acharya

Therapeutics and Clinical Risk Management 2010, 6:29-40

Published Date: 22 December 2009

Update on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria

Pauline Byakika-Kibwika, Mohammed Lamorde, Harriet Mayanja-Kizza, et al

Therapeutics and Clinical Risk Management 2010, 6:11-20

Published Date: 16 December 2009